An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator

[1]  Changyu Shen,et al.  Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices. , 2017, Heart rhythm.

[2]  David S. Hirsh,et al.  Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices , 2017, Pacing and clinical electrophysiology : PACE.

[3]  Jason C. Rubenstein,et al.  Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator , 2017, New England Journal of Medicine.

[4]  K. Fischbach,et al.  MR-Untersuchungen bei Patienten mit Herzschrittmachern und implantierbaren Kardioverter‑Defibrillatoren , 2017, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[5]  R. Passman,et al.  The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices. , 2016, Academic radiology.

[6]  G. Nam,et al.  Cardiac Implantable Electronic Device Safety during Magnetic Resonance Imaging , 2016, Korean circulation journal.

[7]  D. Pennell,et al.  Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers. , 2016, European heart journal cardiovascular Imaging.

[8]  Soo Yong Lee,et al.  Complications of Cardiac Perforation and Lead Dislodgement with an MRI-Conditional Pacing Lead: a Korean Multi-Center Experience , 2016, Journal of Korean medical science.

[9]  P. Mittal,et al.  Safety and Quality of 1.5-T MRI in Patients With Conventional and MRI-Conditional Cardiac Implantable Electronic Devices After Implementation of a Standardized Protocol. , 2016, AJR. American journal of roentgenology.

[10]  M. Gold,et al.  Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment , 2016, Circulation. Cardiovascular imaging.

[11]  Birgit Hailer,et al.  Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla , 2015, Journal of Cardiovascular Magnetic Resonance.

[12]  A. W. M. van der Graaf,et al.  Non-invasive focus localization, right ventricular epicardial potential mapping in patients with an MRI-conditional pacemaker system ‐ a pilot study , 2015, Journal of Interventional Cardiac Electrophysiology.

[13]  M. Turakhia,et al.  Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators , 2015, Journal of magnetic resonance imaging : JMRI.

[14]  M. Hansen,et al.  Optimized protocols for cardiac magnetic resonance imaging in patients with thoracic metallic implants , 2015, Pediatric Radiology.

[15]  S. Wolff,et al.  MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results. , 2015, Heart rhythm.

[16]  Georg Ertl,et al.  Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? , 2015, European heart journal.

[17]  Jagmeet P. Singh,et al.  Increased Perforation Risk with an MRI‐Conditional Pacing Lead: A Single‐Center Study , 2015, Pacing and clinical electrophysiology : PACE.

[18]  Joshua J. E. Blauer,et al.  Wideband late gadolinium enhanced magnetic resonance imaging for imaging myocardial scar without image artefacts induced by implantable cardioverter-defibrillator: a feasibility study at 3 T. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  Bjoern Peters,et al.  Cardiac MRI in patients with complex CHD following primary or secondary implantation of MRI-conditional pacemaker system , 2015, Cardiology in the Young.

[20]  A. Lazarus,et al.  The Kora Pacemaker is Safe and Effective for Magnetic Resonance Imaging , 2015, Clinical Medicine Insights. Cardiology.

[21]  M. Castillo.  History and evolution of brain tumor imaging: insights through radiology. , 2014, Radiology.

[22]  D. Morhard,et al.  Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers , 2014, Journal of Cardiovascular Magnetic Resonance.

[23]  E. Salomonowitz,et al.  Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study , 2014, Journal of Cardiovascular Magnetic Resonance.

[24]  Daniel B Ennis,et al.  Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. , 2014, Heart rhythm.

[25]  D. Gelb,et al.  The impact of MRI on stroke management and outcomes: a systematic review. , 2013, Journal of evaluation in clinical practice.

[26]  Marmar Vaseghi,et al.  Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. , 2013, Radiology.

[27]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[28]  David L. Hayes,et al.  Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. , 2013, Heart rhythm.

[29]  E. Kanal,et al.  ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.

[30]  R. Russo,et al.  Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. , 2012, The American journal of cardiology.

[31]  H. Halperin,et al.  Quantitative Assessment of Artifacts on Cardiac Magnetic Resonance Imaging of Patients With Pacemakers and Implantable Cardioverter-Defibrillators , 2011, Circulation. Cardiovascular imaging.

[32]  R. Fimmers,et al.  Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. , 2011, American heart journal.

[33]  Donald C Pompan.  Appropriate use of MRI for evaluating common musculoskeletal conditions. , 2011, American family physician.

[34]  Ó. Cano,et al.  Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  M. Glikson,et al.  Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. , 2010, The Israel Medical Association journal : IMAJ.

[36]  M. Mollerus,et al.  Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  D. Bluemke,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Journal of the American College of Cardiology.

[38]  Manesh R. Patel,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[39]  F. Romeo,et al.  Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes. , 2010, Heart rhythm.

[40]  Óscar Cano,et al.  Resonancia magnética nuclear en pacientes portadores de dispositivos de estimulación cardiaca , 2010 .

[41]  H. Ghanbari,et al.  A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI) , 2010, Journal of Interventional Cardiac Electrophysiology.

[42]  R. Fimmers,et al.  Evaluation of Cumulative Effects of MR Imaging on Pacemaker Systems at 1.5 Tesla , 2009, Pacing and clinical electrophysiology : PACE.

[43]  J. Gimbel.  Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  A. Roguin.  Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. , 2009, Journal of the American College of Cardiology.

[45]  H. Schild,et al.  Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. , 2009, Journal of the American College of Cardiology.

[46]  E. Kanal,et al.  Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design , 2008, Trials.

[47]  R. Fimmers,et al.  Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. , 2008, Radiology.

[48]  M. Mollerus,et al.  Cardiac Biomarkers in Patients with Permanent Pacemakers and Implantable Cardioverter‐Defibrillators Undergoing an MRI Scan , 2008, Pacing and clinical electrophysiology : PACE.

[49]  J. Gimbel.  Magnetic Resonance Imaging of Implantable Cardiac Rhythm Devices at 3.0 Tesla , 2008, Pacing and clinical electrophysiology : PACE.

[50]  S. Priori,et al.  Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  D. Bluemke,et al.  Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention , 2007, Circulation.

[52]  O. Faris,et al.  Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. , 2006, Circulation.

[53]  Harold Litt,et al.  Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non–Pacemaker-Dependent Patients: A Prospective Study With 115 Examinations , 2006, Circulation.

[54]  H. Halperin,et al.  Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla , 2006, Circulation.

[55]  Ron Kalin,et al.  Current Clinical Issues for MRI Scanning of Pacemaker and Defibrillator Patients , 2005, Pacing and clinical electrophysiology : PACE.

[56]  Emanuel Kanal,et al.  Outcome of Magnetic Resonance Imaging (MRI) in Selected Patients with Implantable Cardioverter Defibrillators (ICDs) , 2005, Pacing and clinical electrophysiology : PACE.

[57]  O. Faris,et al.  Government Viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI , 2005, Pacing and clinical electrophysiology : PACE.

[58]  Henry R. Halperin,et al.  Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T , 2004, Circulation.

[59]  Robert Fair,et al.  Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. , 2004, Journal of the American College of Cardiology.

[60]  Emanuel Kanal,et al.  Can patients with implantable pacemakers safely undergo magnetic resonance imaging? , 2004, Journal of the American College of Cardiology.

[61]  E. Martin,et al.  1147-210 Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 tesia , 2004 .

[62]  Frank G Shellock,et al.  MR Safety and the American College of Radiology White Paper. , 2002, AJR. American journal of roentgenology.

[63]  David L Hayes,et al.  The Revised NASPE/BPEG Generic Code for Antibradycardia, Adaptive‐Rate, and Multisite Pacing , 2002, Pacing and clinical electrophysiology : PACE.

[64]  Thomas G. Maris,et al.  MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences , 2001, European Radiology.

[65]  A. Bernstein,et al.  The NASPE * /BPEG ** Defibrillator Code , 1993 .

[66]  H. Quick,et al.  MR Imaging in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators* , 2017 .

[67]  Y. Okumura,et al.  MRI Mode Programming for Safe Magnetic Resonance Imaging in Patients With a Magnetic Resonance Conditional Cardiac Device. , 2016, International heart journal.

[68]  Andrew S Phelps,et al.  Pairwise comparison versus Likert scale for biomedical image assessment. , 2015, AJR. American journal of roentgenology.

[69]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. , 2014, Revista espanola de cardiologia.

[70]  J. Stockman,et al.  A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices , 2013 .

[71]  Peter Hunold,et al.  Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. , 2011, Heart rhythm.

[72]  Ó. Cano,et al.  Nuclear magnetic resonance imaging in patients with cardiac pacing devices. , 2010, Revista espanola de cardiologia.

[73]  P. Levine.  Pacemaker dependency after pacemaker implantation. , 2007, Cardiology journal.

[74]  A J Camm,et al.  North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code. , 1993, Pacing and clinical electrophysiology : PACE.